PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCorticoids
Corticoids
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2897 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AsthmaD001249EFO_0000270J45—531110
Kidney transplantationD016030——1234—9
ArthritisD001168EFO_0005856M05-M14—15219
Rheumatoid arthritisD001172EFO_0000685M06.9—14117
Liver transplantationD016031EFO_0010682——1—1—2
Juvenile arthritisD001171EFO_1002007M08——11—2
Heart transplantationD016027EFO_0010673———11—2
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lupus nephritisD008181EFO_0005761——14——5
NephritisD009393—N05—14——5
ArteritisD001167EFO_0009011I77.6—11——2
Giant cell arteritisD013700EFO_1001209M31.6—11——2
Polymyalgia rheumaticaD011111EFO_0008518M35.3—11——2
Systemic lupus erythematosusD008180EFO_0002690M32——2——2
Neuromyelitis opticaD009471EFO_0004256G36.0——2——2
Nasal polypsD009298—J33——2——2
PolypsD011127EFO_0000662———2——2
RhinosinusitisD000096825————2——2
Show 10 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223—C85.912———2
Atopic dermatitisD003876EFO_0000274L20—2———2
EczemaD004485—L30.9—2———2
DermatitisD003872—L30.9—2———2
Ischemic optic neuropathyD018917EFO_1000809H47.01—1———1
Follicular lymphomaD008224—C8211———1
Large b-cell lymphoma diffuseD016403—C83.311———1
B-cell lymphomaD016393——11———1
Non-small-cell lung carcinomaD002289———1———1
Lung neoplasmsD008175—C34.90—1———1
Show 4 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938—C951————1
B-cell chronic lymphocytic leukemiaD015451—C91.11————1
Lymphoid leukemiaD007945—C911————1
Covid-19D000086382—U07.11————1
Macular edemaD008269——1————1
UveitisD014605EFO_1001231H20.91————1
EdemaD004487—R60.91————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypersensitivityD006967EFO_0003785T78.40————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
151 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use